Basic information Safety Supplier Related

MS1943

Basic information Safety Supplier Related

MS1943 Basic information

Product Name:
MS1943
Synonyms:
  • MS1943
  • 1,6-Dimethyl-2-aminomethyl-3-benzyloxypyridin-4(1H)-one
  • 1H-Indazole-4-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-[4-[2-[(2-tricyclo[3.3.1.13,7]dec-1-ylacetyl)amino]ethyl]-1-piperazinyl]-3-pyridinyl]-
  • 6-(6-(4-(2-(2-(Adamantan-1-yl)acetamido)ethyl)piperazin-1-yl)pyridin-3-yl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-1H-indazole-4-carboxamide
  • MS 1943,degrader,Histone Methyltransferase,breast,Apoptosis,inhibit,triple-negative,proliferation,methyltransferase,MS1943,cancer,Inhibitor,cytotoxic,MS-1943,TNBC
  • MS1943, 10 mM in DMSO
CAS:
2225938-17-8
MF:
C42H54N8O3
MW:
718.93
Mol File:
2225938-17-8.mol
More
Less

MS1943 Chemical Properties

Density 
1.36±0.1 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
Soluble in DMSO:100.0(Max Conc. mg/mL);139.1(Max Conc. mM)
form 
A solid
pka
12.56±0.46(Predicted)
color 
Light yellow to yellow
More
Less

Safety Information

WGK Germany 
WGK 3
Storage Class
11 - Combustible Solids
More
Less

MS1943 Usage And Synthesis

Uses

MS1943 is used in the preparation of heterocyclic compounds as EZH2 ligands and their compositions and methods for treating EZH2-mediated cancer. MS1943 itself significantly reduces EZH2 protein levels in numerous triple-negative breast cancer

Biological Activity

MS1943 is a potent and selective degrader of EZH2 (enhancer of zeste homolog 2) th at effectively reduces EZH2 levels in cells. MS1943 potently inhibits growth of multiple TNBC cells and in mice xenograft model.

in vivo

MS1943 (150 mg/kg body weight; i.p.; once daily for 36 days) suppresses tumor growth[1].
MS1943 induces apoptosis in the MDA-MB-468 xenograft model[1].
A single i.p. injection of MS1943 at 50 mg/kg body weight achieved a peak plasma concentration (Cmax) of 2.9 μM and resulted in plasma concentrations above its cellular IC50 value for ~2h. A single 150 mg/kg body weight p.o. dose achieved Cmax of 1.1 μM, but plasma concentrations were below the cellular IC50 value[1].

Animal Model:Eight-week-old female BALB/c nude mice (MDA-MB-468 xenografts)[1]
Dosage:150 mg/kg body weight
Administration:i.p.; once daily for 36 days
Result:Suppresses tumor growth.

IC 50

EZH2 methyltransferase: 120 nM (IC50)

MS1943Supplier

Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070 13913916777;
Email
info@chemlin.com.cn
Bide Pharmatech Ltd.
Tel
400-400-164-7117 18317119277
Email
product02@bidepharm.com
Sichuan Wei Keqi Biological Technology Co., Ltd.
Tel
028-81700200 18116577057
Email
3003855609@qq.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com